Skip to main content
TipRanks
Go Ultimate75% OFF

Bone Therapeutics (0R55) Share Price & Analysis

2 Followers

0R55 Stock Chart & Stats

€0.01€0.00(0.00%)
At close: 4:30 PM GMT
€0.01€0.012€0.014Oct 23Dec 11
Day’s Range
EUR 0.01 - EUR 0.02
52-Week Range
EUR 0.01 - EUR 0.02
Previous Close
EUR 0.01
Volume
N/A
Average Volume (3M)
0
Market Cap
EUR 1.31M
Enterprise Value
EUR 3.78M
Total Cash (Recent Filing)
EUR 816.00K
Total Debt (Recent Filing)
EUR 26.79M
Price to Earnings (P/E)
0.1
Beta
-0.01
Next Earnings
Apr 29, 2027 (Est.)
EPS Estimate
N/A
Dividend Yield
N/A

0R55 FAQ

What was Bone Therapeutics’s price range in the past 12 months?
Bone Therapeutics lowest share price was €0.01 and its highest was €0.02 in the past 12 months.
What is Bone Therapeutics’s market cap?
Bone Therapeutics’s market cap is €1.31M.
When is Bone Therapeutics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Bone Therapeutics’s earnings last quarter?
Bone Therapeutics released its earnings results on Sep 26, 2026. The company reported €0 earnings per share for the quarter.
Is Bone Therapeutics overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Bone Therapeutics pay dividends?
Bone Therapeutics pays a dividend of €0.285 which represents an annual dividend yield of ―. See more information on Bone Therapeutics dividends here
What is Bone Therapeutics’s EPS estimate?
Bone Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bone Therapeutics have?
Bone Therapeutics has 652,862,300 shares outstanding.
What happened to Bone Therapeutics’s price movement after its last earnings report?
Bone Therapeutics reported an EPS of €0 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Bone Therapeutics?
Currently, no hedge funds are holding shares in GB:0R55
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology